Canadian Melanoma Conference: Research Frontiers

Alberta Cancer Board
Ultima Vez Modificado: 15 de enero del 2006

Share article


Conference Dates: Thursday, March 2, 2006 to Monday, March 6, 2006
Conference Location: The Fairmont Banff Springs Hotel, Banff, Alberta

Sponsoring Group: Alberta Cancer Board

Conference Web Page URL: http://www.buksa.com

Topics Covered:

  • siRNA guided Approach to Melanoma
  • Treatment Targeted therapy: Sorafenib and ongoing trials
  • Melanogenesis targeted Nanomedicine
  • Signal Transduction Inhibitor for Melanoma Immunotherapy
  • Update and Overview of NCI clinical trials with molecularly targeted agents
  • p53 Suppression: The Potential of EL625
  • Managing the patient with moles & the follow up of patients with Metastatic Melanoma
  • Oncolytic viruses reference to melanoma
  • Development of melanoma vaccine: possible Phase I/II studies

Conference Objectives: What should the next adjuvant melanoma trial be (the experimental arm, what vaccines, what molecules…)? Can we be rational about selecting investigational molecular therapies / methods, based on what we know about the biology of the disease? Is DTIC still the standard in metastatic disease? Have we made any progress in metastatic disease?

Who Should Attend: Medical Oncologists, Surgeons (General, Oncological, Plastics), Dermatologists, Pathologists, Molecular Biologists, Immunologists

Conference Agenda: TBA

Registration Information: For More Information Canadian Melanoma Conference Secretariat BUKSA Conference Management and Program Development Tel: 780.436.0983 Ext. 229 Fax: 780.437.5984 Toll Free (within North America): 866.436.0983 Ext. 229 Email: melanoma@buksa.com.

Conference Fees: Regular: $250.00 (CDN) - Student: $150.00 (CDN) - One Day: $100.00

Continuing Education: Yes


News
But long-term use may reduce risk for endometrial cancer, melanoma, and non-Hodgkin's lymphoma

Nov 11, 2010 - Long-term use of statins for cholesterol control is unlikely to significantly increase or decrease overall cancer risk but may reduce the risk for some individual cancers, according to a study presented at the American Association for Cancer Research's Frontiers in Cancer Prevention Research Conference, held from Nov. 7 to 10 in Philadelphia.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información